Covered recipient · General Payments record
ALEXIS GONZALEZ RIVERA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2024
$14,981.74
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $612.67 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $342.14 | 11 |
| Olympus Latin America, Inc. | $124.96 | 1 |
| E.R. Squibb & Sons, L.L.C. | $71.13 | 3 |
| Janssen Pharmaceuticals, Inc | $51.00 | 2 |
| Organon LLC | $23.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.78 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818390 | CMS |
| ABBVIE INC. | $24.53 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818392 | CMS |
| ABBVIE INC. | $25.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818394 | CMS |
| ABBVIE INC. | $6.65 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818396 | CMS |
| ABBVIE INC. | $28.05 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818398 | CMS |
| ABBVIE INC. | $25.00 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818400 | CMS |
| ABBVIE INC. | $22.74 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818402 | CMS |
| ABBVIE INC. | $124.95 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818404 | CMS |
| ABBVIE INC. | $6.69 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818406 | CMS |
| ABBVIE INC. | $26.75 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818408 | CMS |
| ABBVIE INC. | $25.00 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818410 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101248883 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.07 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101248893 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.06 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101248899 | CMS |
| Janssen Pharmaceuticals, Inc | $25.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078170191 | CMS |
| Janssen Pharmaceuticals, Inc | $26.00 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078171493 | CMS |
| Olympus Latin America, Inc. | $124.96 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099612495 | CMS |
| Organon Llc | $23.44 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136298240 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.